In one paragraphArticle in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
10 authors.
Donna Collins-McMillenBIO5 Institute, University of Arizona, Tucson, Arizona, United States of America.ORCID 0000-0001-6593-1912 Diogo De Oliveira PessoaBioinformatics Shared Resource, Arizona Cancer Center, University of Arizona, Tucson, Arizona, United States of America.
Kristen ZarrellaDepartment of Immunobiology, University of Arizona, Tucson, Arizona, United States of America.
Christopher J ParkinsVaccine and Gene Therapy Institute, Oregon Health Science University, Beaverton, Oregon, United States of America.
Michael DailyVaccine and Gene Therapy Institute, Oregon Health Science University, Beaverton, Oregon, United States of America.
Nathaniel J MoormanDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.ORCID 0000-0003-4952-6858 Jeremy P KamilDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America.ORCID 0000-0001-8422-7656 Patrizia CaposioVaccine and Gene Therapy Institute, Oregon Health Science University, Beaverton, Oregon, United States of America.ORCID 0000-0001-7579-849X Megha PadiBioinformatics Shared Resource, Arizona Cancer Center, University of Arizona, Tucson, Arizona, United States of America.ORCID 0000-0002-3446-4562 Funding
VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2MThe Administrative CoreP01AI127335 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI Patrizia Caposio · 2017 to 2026
$24.6MMechanisms of Human Cytomegalovirus Latency in Primary Human Hematopoietic CellsR01AI079059 · NIAID · UNIVERSITY OF ARIZONA · PI GOODRUM, FELICIA D · 2008 to 2018
$4.4MMechanisms of Human Cytomegalovirus Latency in Primary Human Hematopoietic CellsR37AI079059 · NIAID · UNIVERSITY OF ARIZONA · PI Felicia D Goodrum · 2019 to 2026
$3.3MMolecular Switch Regulating Human Cytomegalovirus Replicative and Latent StatesR01AI143191 · NIAID · UNIVERSITY OF ARIZONA · PI GOODRUM, FELICIA D, KAMIL, JEREMY PHILLIP · 2018 to 2022
$2.7MUnraveling the regulatory circuits that drive Merkel cell carcinomaR01CA251729 · NCI · UNIVERSITY OF ARIZONA · PI PADI, MEGHA · 2021 to 2025
$1.7MNCI NIH HHS P30 CA023074NCI NIH HHS R01 CA251729NIAID NIH HHS P01 AI127335NIAID NIH HHS R01 AI079059NIAID NIH HHS R01 AI143191NIAID NIH HHS R37 AI079059
6 · The paper itselfAbstract
Identifiers
PMID38826434
PMCPMC11142044
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390